Variant report
Variant | esv3507810 |
---|---|
Chromosome Location | chr3:70058712-70066010 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:15)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:70048808..70051544-chr3:70059297..70061000,2 | K562 | blood: |
(count:15 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MITF-1 | chr3:70062671-70062823 | ENSG00000240405 |
2 | lnc-MITF-1 | chr3:70062945-70064469 | ENSG00000240405 |
3 | lnc-MITF-1 | chr3:70062852-70064165 | NONHSAT090374 |
4 | lnc-MITF-1 | chr3:70061568-70061749 | NONHSAT090374 |
5 | lnc-MITF-1 | chr3:70061508-70061749 | ENSG00000240405 |
6 | lnc-MITF-1 | chr3:70062671-70062823 | NR_110000 |
7 | lnc-MITF-1 | chr3:70062945-70064451 | NR_110000 |
8 | lnc-MITF-1 | chr3:70062671-70062823 | NONHSAT090374 |
9 | lnc-MITF-1 | chr3:70062671-70062823 | ENSG00000240405 |
10 | lnc-MITF-1 | chr3:70062671-70062823 | XLOC_002696 |
11 | lnc-MITF-1 | chr3:70062945-70063018 | ENSG00000240405 |
12 | lnc-MITF-1 | chr3:70061508-70061749 | ENSG00000240405 |
13 | lnc-MITF-1 | chr3:70062945-70064449 | XLOC_002696 |
14 | lnc-MITF-1 | chr3:70061508-70061749 | NR_110000 |
15 | lnc-MITF-1 | chr3:70061508-70061749 | XLOC_002696 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000240405 | chromatin interactions |
PLCXD2 | miRNA target sites |
IFIT5 | miRNA target sites |
PLSCR4 | miRNA target sites |
BAMBI | miRNA target sites |
TNRC6A | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558664354 | chr3:70058765-70058766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs566776471 | chr3:70058768-70058769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs373636395 | chr3:70058804-70058805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs367659152 | chr3:70058839-70058840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569249230 | chr3:70058891-70058892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs28863205 | chr3:70058914-70058915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs554852898 | chr3:70058926-70058927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs574644722 | chr3:70059100-70059101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs540420535 | chr3:70059106-70059107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs4269086 | chr3:70059108-70059109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576993176 | chr3:70059219-70059220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545920546 | chr3:70059222-70059223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs9713522 | chr3:70059231-70059232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs4443177 | chr3:70059236-70059237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs6775820 | chr3:70059383-70059384 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs529192627 | chr3:70059384-70059385 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs371119948 | chr3:70059386-70059387 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs561614843 | chr3:70059404-70059405 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs530369510 | chr3:70059431-70059432 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs112921103 | chr3:70059441-70059442 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs6788592 | chr3:70059448-70059449 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs532435173 | chr3:70059473-70059474 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs552660657 | chr3:70059482-70059483 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs6799782 | chr3:70059493-70059494 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs549344429 | chr3:70059518-70059519 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs374582509 | chr3:70059525-70059526 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs554706551 | chr3:70059567-70059568 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs568361079 | chr3:70059677-70059678 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs534112225 | chr3:70059704-70059705 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs541082545 | chr3:70059730-70059731 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs553995717 | chr3:70059749-70059750 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs115558792 | chr3:70059754-70059755 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs368656571 | chr3:70059764-70059765 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs559183831 | chr3:70059788-70059789 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs144527199 | chr3:70059793-70059794 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs186651665 | chr3:70059811-70059812 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs369533094 | chr3:70059824-70059825 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs112587293 | chr3:70059847-70059848 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs374037487 | chr3:70059848-70059849 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs574287822 | chr3:70059904-70059905 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs9817276 | chr3:70059909-70059910 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs530314166 | chr3:70059910-70059911 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs375526450 | chr3:70059915-70059916 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs540540262 | chr3:70059917-70059918 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs560285235 | chr3:70059919-70059920 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs532569274 | chr3:70059966-70059967 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs75081999 | chr3:70059982-70059983 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs145436105 | chr3:70059992-70059993 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs534635897 | chr3:70059995-70059996 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs531759590 | chr3:70060023-70060024 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Prostate cancer | 17217626 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Mental retardation | 20848658 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Mental retardation | 17847001 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:70041200-70061000 | Weak transcription | Aorta | Aorta |
2 | chr3:70055600-70059800 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
3 | chr3:70055800-70059600 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
4 | chr3:70055800-70059800 | Weak transcription | Primary monocytes fromperipheralblood | blood |
5 | chr3:70055800-70061600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
6 | chr3:70059600-70060000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
7 | chr3:70059600-70061400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
8 | chr3:70059800-70060200 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr3:70059800-70060200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
10 | chr3:70060400-70061200 | Enhancers | Colon Smooth Muscle | Colon |
11 | chr3:70060400-70061600 | Enhancers | Fetal Stomach | stomach |
12 | chr3:70060800-70061600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
13 | chr3:70061000-70061400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
14 | chr3:70061000-70061400 | Enhancers | Aorta | Aorta |
15 | chr3:70061000-70061400 | Enhancers | Pancreas | Pancrea |
16 | chr3:70061000-70061800 | Enhancers | Rectal Smooth Muscle | rectum |
17 | chr3:70061400-70061800 | Active TSS | Aorta | Aorta |
18 | chr3:70061600-70063200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
19 | chr3:70061800-70062600 | Weak transcription | Aorta | Aorta |
20 | chr3:70062000-70063200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
21 | chr3:70062600-70063800 | Enhancers | Aorta | Aorta |
22 | chr3:70063200-70065800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
23 | chr3:70063800-70098000 | Weak transcription | Aorta | Aorta |
24 | chr3:70065000-70065400 | Enhancers | Dnd41 | blood |